| Mrs Tera Elizabeth Givens, CNM | |
|
1318 Harrison Ave, Mccomb, MS 39648-2830 | |
| (601) 684-2300 | |
| Not Available |
| Full Name | Mrs Tera Elizabeth Givens |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 1318 Harrison Ave, Mccomb, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396436143 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 899584 (Mississippi) | Primary |
| Entity Name | Southwest Mississippi Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982174488 PECOS PAC ID: 5193633907 Enrollment ID: O20080512000004 |
News Archive
A Massachusetts General Hospital research team has discovered a possible mechanism behind the elevated risk of cardiovascular disease in women infected with HIV, a risk even higher than that of HIV-infected men. In the Dec. 1 issue of the Journal of Infectious Diseases the investigators report finding that HIV-infected women had a greater prevalence of the type of coronary artery plaque most vulnerable to rupture than did uninfected women.
California state Sen. Sheila Kuehl (D) on Tuesday for the third time introduced legislation (SB 840) that would eliminate health insurers and create a state-run, single-payer health insurance system, the Los Angeles Times reports.
Targeted Genetics Corporation announced that its partner, Celladon Corporation, presented full data today that show the first Phase II trial with MYDICAR® for the treatment of advanced heart failure has met its primary safety and efficacy endpoints, as prospectively defined in the Phase II trial protocol.
Doctors from around the UK are taking part in one of the world's largest lung cancer clinical trials investigating how a blood thinning drug might help prevent blood clots in lung cancer patients.
The findings from a study by a team based at the London School of Hygiene & Tropical Medicine (LSHTM) are published in PLoS Medicine.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Tera Elizabeth Givens, CNM 1318 Harrison Ave, Mccomb, MS 39648-2830 Ph: (601) 684-2300 | Mrs Tera Elizabeth Givens, CNM 1318 Harrison Ave, Mccomb, MS 39648-2830 Ph: (601) 684-2300 |
News Archive
A Massachusetts General Hospital research team has discovered a possible mechanism behind the elevated risk of cardiovascular disease in women infected with HIV, a risk even higher than that of HIV-infected men. In the Dec. 1 issue of the Journal of Infectious Diseases the investigators report finding that HIV-infected women had a greater prevalence of the type of coronary artery plaque most vulnerable to rupture than did uninfected women.
California state Sen. Sheila Kuehl (D) on Tuesday for the third time introduced legislation (SB 840) that would eliminate health insurers and create a state-run, single-payer health insurance system, the Los Angeles Times reports.
Targeted Genetics Corporation announced that its partner, Celladon Corporation, presented full data today that show the first Phase II trial with MYDICAR® for the treatment of advanced heart failure has met its primary safety and efficacy endpoints, as prospectively defined in the Phase II trial protocol.
Doctors from around the UK are taking part in one of the world's largest lung cancer clinical trials investigating how a blood thinning drug might help prevent blood clots in lung cancer patients.
The findings from a study by a team based at the London School of Hygiene & Tropical Medicine (LSHTM) are published in PLoS Medicine.
› Verified 7 days ago